Oruka Therapeutics, Inc.

ORKA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 20, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Oct 15, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
144 Oct 15, 2026
4 Oct 13, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
144 Oct 13, 2026
4 Oct 2, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
144 Oct 1, 2026
4 Sep 21, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Sep 21, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
144 Sep 21, 2026
4 Sep 15, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Sep 15, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Sep 15, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Sep 15, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Sep 15, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Sep 1, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Sep 1, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
144 Sep 1, 2026
144 Sep 1, 2026
424B5 Aug 28, 2026 PROSPECTUS
EFFECT Aug 27, 2026
4 Aug 25, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
3 Aug 25, 2026 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
8-K Aug 24, 2026 CURRENT REPORT
S-3 Aug 21, 2026 REGISTRATION STATEMENT
← Newer Page 1 of 60 · 1480 filings Older →